$20M Series A raise supported
A capital-introduction campaign spanning family offices, international VCs, and strategic industry partners.
Published Updated
The numbers reported.
Capital sourced or raises supported are not capital committed. These outcomes reflect this client engagement and are not a guarantee of future performance.
What did Seqnced do for Innova Vascular?
Innova Vascular was pursuing a $20M Series A equity raise but had difficulty reaching aligned family offices and international venture investors. The company also needed access to strategic groups capable of supporting both capital formation and a potential future transaction.
Seqnced mapped family offices, international VCs, and strategic medtech counterparties, then operated a focused introduction campaign around the raise and the company's vascular-device platform.
- $20M Series A equity raise supported
- Potential capital partners introduced across family offices and international VCs
- Strategic conversation opened with W. L. Gore
- $20M Series A equity raise supported
- Potential capital partners introduced across family offices and international VCs
- Strategic conversation opened with W. L. Gore
